Risk factors for persistent atrial fibrillation following successful hyperthyroidism treatment with radioiodine therapy

Internal Medicine

Volumn 50, Issue 24, 2011, Pages 2947-2951

  Zhou, Zhen Hu ^a   Ma, Long Le ^a,b   Wang, Le Xin ^a,b  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Atrial fibrillation; ECG; Holter monitoring; Hyperthyroidism; Radioiodine

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; ARTICLE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HOLTER MONITORING; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 83755194681     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.6135     Document Type: Article

References (13)

1. Biondi B, Kahaly GJ. Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol 6: 431 443, 2010.
2. Boelaert K, Torlinska B, Holder RL, Franklyn JA. Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study. J Clin Endocrinol Metab 95: 2715-2726, 2010.
3. Siu CW, Jim MH, Zhang X, et al. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation. Am J Cardiol 103: 540-543, 2009.
4. Scott GR, Forfar JC, Toft AD. Graves' disease and atrial fibrillation: the case for even higher doses of therapeutic iodine-131. Br Med J 289: 399-400, 1984.
5. Vaidya B, Williams GR, Abraham P, Pearce SH. Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists. Clin Endocrinol 68: 814-820, 2008.
6. Metso S, Auvinen A, Salmi J, Huhtala H, Jaatinen P. Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism. Clin Endocrinol 68: 450 457, 2008.
7. Klein I, Danzi S. Thyroid disease and the heart. Circulation 116: 1725-1735, 2007.
8. de Rooij A, Vandenbroucke JP, Smit JW, Stokkel MP, Dekkers OM. Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis. Eur J Endocrinol 161: 771-777, 2009.
9. Nakazawa H, Lythall DA, Noh J, et al. Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation. Eur Heart J 21: 327-333, 2000.
10. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31: 2369-2429, 2010.
11. Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H. Hyperthyroidism and the management of atrial fibrillation. Thyroid 12: 489-493, 2002.
12. Petersen P, Hansen JM. Stroke in thyrotoxicosis with atrial fibrillation. Stroke 19: 15-18, 1998.
13. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Circulation 114: 700-752, 2006.